Suchergebnisse - Nina Radosevic‐Robin
- Treffer 1 - 15 von 15
-
1
Quantification of HER family receptors in breast cancer von Paolo Nucíforo, Nina Radosevic‐Robin, Tony Ng, Maurizio Scaltriti
Veröffentlicht 2015Revisão -
2
Analysis of tumour-infiltrating lymphocytes reveals two new biologically different subgroups of breast ductal carcinoma in situ von Marie Béguinot, Marie-Mélanie Dauplat, Fabrice Kwiatkowski, Guillaume Lebouëdec, L. Tixier, Christophe Pomel, Frédérique Penault–Llorca, Nina Radosevic‐Robin
Veröffentlicht 2018Artigo -
3
-
4
-
5
Homoharringtonine, an approved anti-leukemia drug, suppresses triple negative breast cancer growth through a rapid reduction of anti-apoptotic protein abundance. von Mohamad Yakhni, Arnaud Briat, Abderrahim El Guerrab, Ludivine Furtado, Fabrice Kwiatkowski, Elisabeth Miot-Noirault, F. Cachin, Frédérique Penault‐Llorca, Nina Radosevic‐Robin
Veröffentlicht 2019Artigo -
6
Therapeutic Activity of Anti-AXL Antibody against Triple-Negative Breast Cancer Patient-Derived Xenografts and Metastasis von Wilhem Leconet, Myriam Chentouf, Stanislas du Manoir, Clément Chevalier, Audrey Sirvent, Imade Aït-Arsa, Muriel Busson, Marta Jarlier, Nina Radosevic‐Robin, Charles Theillet, Dany Chalbos, Jean‐Max Pasquet, André Pèlegrin, Christel Larbouret, Bruno Robert
Veröffentlicht 2016Artigo -
7
An auristatin‐based antibody‐drug conjugate targeting HER3 enhances the radiation response in pancreatic cancer von Laura Bourillon, C. Bourgier, Nadège Gaborit, Véronique Garambois, Eva Llès, Alexandre Zampieri, Charline Ogier, Marta Jarlier, Nina Radosevic‐Robin, Béatrice Orsetti, Hélène Delpech, Charles Theillet, Pierre‐Emmanuel Colombo, D. Azria, André Pèlegrin, Christel Larbouret, Thierry Chardès
Veröffentlicht 2019Artigo -
8
HER3 as biomarker and therapeutic target in pancreatic cancer: new insights in pertuzumab therapy in preclinical models von Gaëlle Thomas, Thierry Chardès, Nadège Gaborit, Caroline Mollévi, Wilhem Leconet, Bruno Robert, Nina Radosevic‐Robin, Frédérique Penault‐Llorca, Céline Gongora, Pierre‐Emmanuel Colombo, Yassamine Lazrek, Rui Bras-Gonçalves, Ariel Savina, D. Azria, Hervé Bazin, André Pèlegrin, Christel Larbouret
Veröffentlicht 2014Artigo -
9
Multicentric neoadjuvant pilot Phase II study of cetuximab combined with docetaxel in operable triple negative breast cancer von Jean‐Marc Nabholtz, Nasséra Chalabi, Nina Radosevic‐Robin, M. -M. Dauplat, M-A Mouret-Reynier, Isabelle Van Praagh, V. Servent, J.P. Jacquin, Kheir-Eddine Benmammar, Sharif Kullab, M.R.K. Bahadoor, Fabrice Kwiatkowski, Anne Cayre, Catherine Abrial, Xavier Durando, Y.-J. Bignon, P. Chollet, Frédérique Penault‐Llorca
Veröffentlicht 2015Artigo -
10
Infiltrating and peripheral immune cell analysis in advanced gastric cancer according to the Lauren classification and its prognostic significance von Simon Pernot, Magali Terme, Nina Radosevic‐Robin, Florence Castan, Cécile Badoual, Elie Marcheteau, Frédérique Penault‐Llorca, Olivier Bouché, Jaafar Bennouna, Éric François, François Ghiringhelli, Christelle de la Fouchardière, Emmanuelle Samalin, Jean‐Baptiste Bachet, Christophe Borg, Valérie Boige, Thibault Voron, Trevor Stanbury, Éric Tartour, Sophie Gourgou, David Malka, Julien Taı̈eb
Veröffentlicht 2019Artigo -
11
Antagonism of EGFR and HER3 Enhances the Response to Inhibitors of the PI3K-Akt Pathway in Triple-Negative Breast Cancer von Jessica J. Tao, Pau Castel, Nina Radosevic‐Robin, Moshe Elkabets, Neil Auricchio, Nicola Aceto, Gregory Weitsman, Paul R. Barber, Borivoj Vojnovic, Haley Ellis, Natasha Morse, Nerissa T. Viola, Ana Bosch, Dejan Juric, Saswati Hazra, Sharat Singh, Phillip Kim, Anna Bergamaschi, Shyamala Maheswaran, Tony Ng, Frédérique Penault‐Llorca, Jason S. Lewis, Lisa A. Carey, Charles M. Perou, José Baselga, Maurizio Scaltriti
Veröffentlicht 2014Artigo -
12
Multicentric neoadjuvant phase II study of panitumumab combined with an anthracycline/taxane-based chemotherapy in operable triple-negative breast cancer: identification of biologi... von Jean‐Marc Nabholtz, Catherine Abrial, Marie‐Ange Mouret‐Reynier, Marie-Mélanie Dauplat, B. Weber, Joseph Gligorov, Amélie Forest, Olivier Trédan, Laurence Vanlemmens, Thierry Petit, Séverine Guiu, Isabelle Van Praagh, Christelle Jouannaud, Pascale Dubray‐Longeras, N. Tubiana-Mathieu, Kheir-Eddine Benmammar, Sharif Kullab, M.R.K. Bahadoor, Nina Radosevic‐Robin, Fabrice Kwiatkowski, Alexis Desrichard, Anne Cayre, Nancy Uhrhammer, Nasséra Chalabi, P. Chollet, Frédérique Penault‐Llorca
Veröffentlicht 2014Artigo -
13
Update on tumor-infiltrating lymphocytes (TILs) in breast cancer, including recommendations to assess TILs in residual disease after neoadjuvant therapy and in carcinoma in situ: A... von Maria Vittoria Dieci, Nina Radosevic‐Robin, Susan Fineberg, Gert Van den Eynden, Nils Ternès, Frédérique Penault‐Llorca, Giancarlo Pruneri, Timothy M. D’Alfonso, Sandra Demaria, Carlos A. Castañeda, Joselyn Sanchez, Sunil Badve, Stefan Michiels, Veerle Bossuyt, Federico Rojo, Baljit Singh, Torsten O. Nielsen, Giuseppe Viale, Seong-Rim Kim, Stephen M. Hewitt, Stephan Wienert, Sybille Loibl, David L. Rimm, Fraser Symmans, Carsten Denkert, Sylvia Adams, Sherene Loi, Roberto Salgado
Veröffentlicht 2017Revisão -
14
Stratification and therapeutic potential of PML in metastatic breast cancer von Natalia Martín-Martín, Marco Piva, Jelena Urosevic, Paula Aldaz, James D. Sutherland, Sonia Fernández‐Ruiz, Leire Arreal, Verónica Torrano, Ana R. Cortázar, Evarist Planet, Marc Guiu, Nina Radosevic‐Robin, Stéphane Garcia, Iratxe Macías, Fernando Salvador, Giacomo Domenici, Oscar M. Rueda, Amaia Zabala-Letona, Amaia Arruabarrena-Aristorena, Patricia Zúñiga-García, Alfredo Caro‐Maldonado, Lorea Valcárcel-Jiménez, Pilar Sánchez‐Mosquera, Marta Varela‐Rey, María Luz Martínez‐Chantar, Juan Anguíta, Yasir H. Ibrahim, Maurizio Scaltriti, Charles H. Lawrie, Ana M. Aransay, Juan Iovanna, José Baselga, Carlos Caldas, Rosa Barrio, Violeta Serra, María dM Vivanco, Ander Matheu, Roger R. Gomis, Arkaitz Carracedo
Veröffentlicht 2016Artigo -
15
Standardized evaluation of tumor-infiltrating lymphocytes in breast cancer: results of the ring studies of the international immuno-oncology biomarker working group von Carsten Denkert, Stephan Wienert, Audrey Poterie, Sibylle Loibl, Jan Budczies, Sunil Badve, Zsuzsanna Bagó-Horváth, Anita Bane, Shahinaz Bedri, Jane B. Brock, Ewa Chmielik, Matthias Christgen, Cécile Colpaert, Sandra Demaria, Gert Van den Eynden, Giuseppe Floris, Stephen B. Fox, Dongxia Gao, Barbara Ingold Heppner, S Rim Kim, Zuzana Kos, Hans Kreipe, Sunil R. Lakhani, Frédérique Penault‐Llorca, Giancarlo Pruneri, Nina Radosevic‐Robin, David L. Rimm, Stuart J. Schnitt, Bruno V. Sinn, Hans‐Peter Sinn, Nicolas Sirtaine, Sandra A. O’Toole, Giuseppe Viale, Koen Van de Vijver, Roland de Wind, Gϋnter von Minckwitz, Frederick Klauschen, Michael Untch, Peter A. Fasching, Toralf Reimer, Karen Willard‐Gallo, Stefan Michiels, Sherene Loi, Roberto Salgado
Veröffentlicht 2016Artigo
Suchwerkzeuge:
Ähnliche Schlagworte
Cancer
Internal medicine
Medicine
Breast cancer
Biology
Oncology
Cancer research
Genetics
Biochemistry
Triple-negative breast cancer
Cancer cell
Cetuximab
Colorectal cancer
Immunology
Neoadjuvant therapy
Pathology
Surgical oncology
Apoptosis
Bioinformatics
Biomarker
Biotechnology
Cell biology
Cell culture
Chemistry
Chemotherapy
Clinical endpoint
Clinical trial
Docetaxel
Ductal carcinoma
Epidermal growth factor receptor